» Authors » Elizaveta Chabanova

Elizaveta Chabanova

Explore the profile of Elizaveta Chabanova including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 53
Citations 746
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Pedersen R, Fraulund M, Chabanova E, Holm L, Hansen T, Thomsen H, et al.
Child Obes . 2025 Jan; PMID: 39841082
Steatotic liver disease (SLD) represents a multisystem disease and is a common complication of childhood obesity. We studied fat content at the abdominal level (liver, subcutaneous, and visceral) and the...
2.
Mogensen C, Magkos F, Chabanova E, Molgaard C, Geiker N
Obesity (Silver Spring) . 2025 Jan; 33(2):238-242. PMID: 39749416
Objective: The study objective was to evaluate changes in abdominal adipose tissue and ectopic fat during pregnancy and their associations with gestational weight gain (GWG) in women with overweight/obesity. Methods:...
3.
Sandby K, Krarup T, Chabanova E, Geiker N, Magkos F
J Clin Endocrinol Metab . 2024 Aug; PMID: 39150984
Context: Studies in heterogenous groups of people with respect to sex, body mass index (BMI), and glycemic status (normoglycemia, impaired glucose tolerance, diabetes), indicate no relationship between liver fat accumulation...
4.
Rix I, Lund A, Garvey L, Hansen C, Chabanova E, Hartmann B, et al.
Eur J Endocrinol . 2024 May; 190(6):446-457. PMID: 38781444
Objective: The metabolic phenotype of totally pancreatectomised patients includes hyperaminoacidaemia and predisposition to hypoglycaemia and hepatic lipid accumulation. We aimed to investigate whether the loss of pancreatic glucagon may be...
5.
Sandby K, Magkos F, Chabanova E, Petersen E, Krarup T, Bertram H, et al.
Clin Nutr . 2024 Jan; 43(2):534-542. PMID: 38232682
Background & Aims: In recent years, epidemiological studies have reported links between the consumption of fermented dairy products, such as yogurt, and health; however, evidence from human intervention trials is...
6.
Suppli M, Hogedal A, Bagger J, Chabanova E, van Hall G, Forman J, et al.
J Clin Endocrinol Metab . 2023 Nov; 109(4):955-967. PMID: 37967235
Context: Hyperglucagonemia is observed in individuals with obesity and contributes to the hyperglycemia of patients with type 2 diabetes. Hyperglucagonemia may develop due to steatosis-induced hepatic glucagon resistance resulting in...
7.
Rix I, Johansen M, Lund A, Suppli M, Chabanova E, van Hall G, et al.
Endocr Connect . 2023 Nov; 13(1). PMID: 37947763
Aims: Hyperglucagonaemia contributes to the pathophysiology in type 2 diabetes (T2D), but the mechanisms behind the inappropriate glucagon secretion are not fully understood. Glucagon and amino acids are regulated in...
8.
Huang Y, Stinson S, Juel H, Lund M, Holm L, Fonvig C, et al.
Liver Int . 2023 May; 43(8):1772-1782. PMID: 37208954
Background & Aims: Genome-wide association studies have identified steatogenic variants that also showed pleiotropic effects on cardiometabolic traits in adults. We investigated the effect of eight previously reported genome-wide significant...
9.
Hellmann P, Bagger J, Carlander K, Hansen K, Forman J, Storling J, et al.
Endocr Connect . 2023 Feb; 12(4). PMID: 36800259
Objectives: Preclinically, curcumin has been shown to protect against glucocorticoid-induced insulin resistance. We evaluated the effect of curcumin administered with prednisolone in healthy overweight or obese men. Methods: In a...
10.
Ingersen A, Helset H, Calov M, Chabanova E, Harreskov E, Jensen C, et al.
Front Physiol . 2022 Dec; 13:1061063. PMID: 36531168
Alternate-day fasting induces oscillations in energy stores. We hypothesized that repeated oscillations increases insulin secretion and sensitivity, and improve metabolic health in patients with obesity with or without type 2...